The TNT trial: A randomized phase III trial of carboplatin (C) compared with docetaxel (D) for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer (CRUK/07/012)

Authors
Category Primary study
JournalCANCER RESEARCH
Year 2015
This article has no abstract
Epistemonikos ID: a430ce8d24cbbd9c2732df91963a82b3ab2b4ed3
First added on: Feb 07, 2025